3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Advanced Solid Tumor
104
Advanced Solid Tumors
92
Solid Tumor
69
Mesothelioma
42
Mesothelioma, Malignant
41
Solid Tumors
37
Carcinoma, Non-Small-Cell Lung
25
Solid Tumor, Adult
22
Stomach Neoplasms
15
Ovarian Neoplasms
15
Esophageal Neoplasms
15
Melanoma
13
Colorectal Neoplasms
13
Carcinoma, Renal Cell
13
Endometrial Neoplasms
11
Unspecified Adult Solid Tumor, Protocol Specific
10
Pancreatic Neoplasms
10
Neoplasms
10
Neoplasm Metastasis
10
Advanced Malignant Solid Tumor
10
Uterine Cervical Neoplasms
9
Malignant Solid Tumor
9
Lung Neoplasms
9
Breast Neoplasms
9
Triple Negative Breast Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Sarcoma
8
Advanced or Metastatic Solid Tumors
8
Carcinoma, Hepatocellular
7
Small Cell Lung Carcinoma
6
Interventions
spartalizumab
1
pazopanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Refractory or Recurrent Solid Tumor
×
Other solid neoplasm
×
Clear all
NCT05210413
2026-01-15
SPARTO
University Hospital, Bordeaux
Phase 1/2
Active not recruiting
80 enrolled